133 related articles for article (PubMed ID: 30106633)
21. Propylthiouracil-induced vasculitic oral ulcers with anti-neutrophil cytoplasmic antibody.
Karincaoglu Y; Esrefoglu M; Aki T; Mizrak B
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):120-2. PubMed ID: 16405633
[No Abstract] [Full Text] [Related]
22. Occult pulmonary hemorrhage as a rare presentation of propylthiouracil-induced vasculitis.
Tu YL; Tsai YC; Huang JL; Yao TC
Pediatrics; 2011 Jan; 127(1):e245-9. PubMed ID: 21135005
[TBL] [Abstract][Full Text] [Related]
23. A case of propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis successfully treated with radioactive iodine.
Bes C; Dikbaş O; Keskin E; Kaptanoğulları Ö; Soy M
Reumatismo; 2013 Jul; 65(3):131-3. PubMed ID: 23884029
[TBL] [Abstract][Full Text] [Related]
24. Cryoglobulins and multispecific antineutrophil cytoplasmic antibodies in propylthiouracil-induced necrotizing cutaneous vasculitis--a new association.
Zivanovic D; Dobrosavljevic D; Nikolic M; Bonaci-Nikolic B
Eur J Dermatol; 2012; 22(5):707-9. PubMed ID: 22858991
[No Abstract] [Full Text] [Related]
25. A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
Watanabe-Kusunoki K; Abe N; Nakazawa D; Karino K; Hattanda F; Fujieda Y; Nishio S; Yasuda S; Ishizu A; Atsumi T
Medicine (Baltimore); 2019 Apr; 98(17):e15328. PubMed ID: 31027105
[TBL] [Abstract][Full Text] [Related]
26. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody.
Ohtsuka M; Yamashita Y; Doi M; Hasegawa S
Eur Respir J; 1997 Jun; 10(6):1405-7. PubMed ID: 9192950
[TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed after 17 years of propylthiouracil therapy.
Taguchi T; Nakayama S; Fujimoto S; Terada Y
Endocrine; 2014 Jun; 46(2):357-9. PubMed ID: 24272591
[No Abstract] [Full Text] [Related]
28. Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis.
Prendecki M; Martin L; Tanna A; Antonelou M; Pusey CD
J Rheumatol; 2018 May; 45(5):686-689. PubMed ID: 29545453
[TBL] [Abstract][Full Text] [Related]
29. PTU-associated vasculitis.
Bombassei GJ
Endocr Pract; 2003; 9(2):167. PubMed ID: 12917084
[No Abstract] [Full Text] [Related]
30. Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies (ANCA) skin vasculitis: the first case reported in Croatia.
Anić B; Baresić M; Cerovec M; Mayer M; Bosnić D; Sentić M; Cikes N
Acta Dermatovenerol Croat; 2010; 18(2):104-6. PubMed ID: 20624360
[TBL] [Abstract][Full Text] [Related]
31. Images in thyroidology. Vasculitis secondary to treatment with propylthiouracil.
Meister LH; Guerra IR; Carvalho GD
Thyroid; 2001 Feb; 11(2):199-200. PubMed ID: 11288992
[No Abstract] [Full Text] [Related]
32. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
[TBL] [Abstract][Full Text] [Related]
33. Propylthiouracil-induced vasculitis presenting as purpuric plaques on cheeks.
Wada S; Namiki T; Miura K; Miyazaki Y
Clin Exp Dermatol; 2022 Mar; 47(3):581-582. PubMed ID: 34637160
[No Abstract] [Full Text] [Related]
34. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
35. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
36. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody.
Criado PR; Grizzo Peres Martins AC; Gaviolli CF; Alavi A
Int J Low Extrem Wounds; 2015 Jun; 14(2):187-91. PubMed ID: 25256279
[TBL] [Abstract][Full Text] [Related]
37. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy.
Otsuka S; Kinebuchi A; Tabata H; Yamakage A; Yamazaki S
Br J Dermatol; 2000 Apr; 142(4):828-30. PubMed ID: 10792251
[No Abstract] [Full Text] [Related]
38. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].
Fujii A; Arimura Y; Minoshima S; Kobayashi M; Yoshihara K; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Takahashi H
Ryumachi; 1997 Dec; 37(6):788-93. PubMed ID: 9492566
[TBL] [Abstract][Full Text] [Related]
39. Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis.
Miller RM; Darben TA; Nedwich J; Savige J
Br J Dermatol; 1999 Nov; 141(5):943-4. PubMed ID: 10583195
[No Abstract] [Full Text] [Related]
40. Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus.
Yamada A; Sato K; Hara M; Tochimoto A; Takagi S; Hizuka N; Takano K
Intern Med; 2002 Dec; 41(12):1204-8. PubMed ID: 12521217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
